MELOTTI, Paola Maria
 Distribuzione geografica
Continente #
NA - Nord America 5.792
EU - Europa 5.104
AS - Asia 3.849
SA - Sud America 550
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 86
OC - Oceania 20
Totale 15.544
Nazione #
US - Stati Uniti d'America 5.621
RU - Federazione Russa 1.891
SG - Singapore 1.381
CN - Cina 1.245
GB - Regno Unito 1.139
IT - Italia 584
BR - Brasile 426
VN - Vietnam 418
SE - Svezia 292
DE - Germania 288
HK - Hong Kong 252
FR - Francia 224
FI - Finlandia 204
IE - Irlanda 204
KR - Corea 120
CA - Canada 115
IN - India 64
BD - Bangladesh 62
TR - Turchia 61
JP - Giappone 48
UA - Ucraina 46
ID - Indonesia 43
NL - Olanda 37
ES - Italia 34
PL - Polonia 34
AR - Argentina 33
IQ - Iraq 32
BE - Belgio 30
MX - Messico 26
AT - Austria 25
CO - Colombia 22
NG - Nigeria 20
EC - Ecuador 19
ZA - Sudafrica 17
UZ - Uzbekistan 16
PK - Pakistan 15
VE - Venezuela 14
AU - Australia 12
IR - Iran 11
PY - Paraguay 11
PE - Perù 10
CL - Cile 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
LT - Lituania 8
PH - Filippine 8
AL - Albania 7
BJ - Benin 7
IL - Israele 7
NZ - Nuova Zelanda 7
SA - Arabia Saudita 7
TG - Togo 7
EG - Egitto 6
MY - Malesia 6
DO - Repubblica Dominicana 5
JO - Giordania 5
LV - Lettonia 5
MA - Marocco 5
NP - Nepal 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
GR - Grecia 4
KE - Kenya 4
KG - Kirghizistan 4
PR - Porto Rico 4
PT - Portogallo 4
UY - Uruguay 4
CR - Costa Rica 3
CY - Cipro 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CD - Congo 1
Totale 15.380
Città #
Southend 964
Singapore 719
Ashburn 665
Moscow 650
San Jose 592
Chandler 581
Dallas 427
Jacksonville 292
Woodbridge 290
Verona 256
Hong Kong 247
Ann Arbor 220
Beijing 218
Dublin 199
Council Bluffs 165
Houston 155
New York 154
The Dalles 114
Ho Chi Minh City 111
Los Angeles 103
Munich 98
Jinan 91
Wilmington 85
Princeton 72
Lawrence 71
Nanjing 71
Shenyang 70
Hanoi 66
Santa Clara 62
Dong Ket 61
Helsinki 53
Tianjin 47
Turku 45
Buffalo 40
São Paulo 39
Montreal 37
Tokyo 37
Seoul 36
Hebei 35
Guangzhou 34
Nanchang 33
Orem 33
Redondo Beach 33
Milan 31
Ningbo 31
Haikou 30
Brussels 29
Jakarta 29
Toronto 29
London 27
Zhengzhou 27
Changsha 26
Lancaster 26
Hangzhou 24
Jiaxing 24
Seattle 24
Taiyuan 24
Warsaw 24
Chennai 23
Frankfurt am Main 23
Sindelfingen 23
Taizhou 23
Rome 22
Stockholm 22
Da Nang 21
Brooklyn 20
San Francisco 20
Vienna 20
Abuja 19
Boardman 19
Columbus 18
Fairfield 18
Madrid 18
Phoenix 18
Amsterdam 17
Falls Church 17
Boston 16
Chicago 16
Washington 16
Atlanta 15
Bologna 15
Poplar 15
Tashkent 15
Barnet 14
Nuremberg 14
Rio de Janeiro 14
Lappeenranta 13
Belo Horizonte 12
Denver 12
Haiphong 12
Paris 12
Charlotte 11
Elora 11
Johannesburg 11
Norwalk 11
Brasília 10
Istanbul 10
Manchester 10
Redwood City 10
Shanghai 10
Totale 9.442
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 410
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 312
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 298
Detection of CFTR protein in human leukocytes by flow cytometry. 292
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 290
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 275
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 269
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 268
Analysis of CFTR function in human monocytes 268
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 249
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 245
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 242
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 238
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 236
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 233
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 228
Combining standardized and new CFTR functional tests for diagnosis 225
Poster Session Abstracts 222
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 217
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 213
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 212
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 210
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 207
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 207
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 207
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 206
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 204
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 202
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 202
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 201
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 200
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 199
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 199
In vivo monitoring of lung inflammation in CFTR-deficient mice 195
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 194
New clinical diagnostic procedures for cystic fibrosis in Europe. 191
20 In vivo monitoring of lung inflammation in CFTR–/– mice 188
Poster Session Abstracts 183
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 180
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 178
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 178
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 174
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 174
Poster Session Abstracts 172
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 169
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 169
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 168
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 168
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 168
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 166
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 166
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 165
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 164
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 162
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 160
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 158
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 158
Poster Session Abstracts 156
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 155
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 152
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 151
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 151
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 150
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 149
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 147
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers 146
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 145
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 142
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 140
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 130
Oxidative stress and antioxidant therapy in cystic fibrosis 129
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 127
Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids 125
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 123
RELEVANCE OF HLA-G IN CF 123
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 120
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 120
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 119
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 118
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 109
The role of macrophages and their scavenger receptors in cystic fibrosis 106
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 95
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 74
Comparison of Preclinical Drug Efficacy in Nasal and Intestinal Patient-Derived Models of Cystic Fibrosis 36
Drug Responsiveness in Patient-Derived Rectal Organoids Correlates with Clinical Response in CF Subjects: A Real-Life Analysis 22
CFTR Modulator Response in Nasal Organoids Derived from People with Cystic Fibrosis 15
Analysis of virulence of the emerging opportunistic human pathogen Achromobacter in a zebrafish embryo model 15
Differential Evolution of Achromobacter spp. Isolates in Upper and Lower Airways of People with Cystic Fibrosis 12
Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations 8
Totale 15.544
Categoria #
all - tutte 52.209
article - articoli 28.895
book - libri 0
conference - conferenze 23.314
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022408 0 0 0 43 45 19 8 28 27 28 52 158
2022/20231.472 113 175 109 267 115 359 17 79 171 8 40 19
2023/2024824 52 57 51 82 79 158 33 54 37 45 126 50
2024/20252.178 98 126 82 370 80 80 177 74 308 153 245 385
2025/20266.428 404 316 412 1.023 1.654 441 540 398 544 400 116 180
2026/2027740 87 147 233 273 0 0 0 0 0 0 0 0
Totale 15.544